Clinical Trial Update: Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing deoxynucleosides pyrimidines for mitochondrial depletion syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Diseases
• Mitochondrial Dna Depletion Syndromes
• Mitochondrial Encephalomyopathy
• Mitochondrial Metabolism Disorders

Drugs mentioned

• Deoxynucleosides Pyrimidines (deoxynucleosides pyrimidines)

Snippet

Sponsor: Kenneth Myers, MD | Conditions: Mitochondrial Diseases, Mitochondrial Encephalomyopathy | Phase 2 | Status: RECRUITING